A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Incyte Corporation
Eureka Therapeutics Inc.
Incyte Corporation
Pfizer
University of Virginia
Incyte Corporation
Sotio Biotech Inc.
Molecular Templates, Inc.
University of Florida
Fate Therapeutics
Children's National Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University Hospital, Ghent
Eli Lilly and Company
University of Chicago
University of Erlangen-Nürnberg Medical School
Polaris Group
University of Utah
Aeon Therapeutics (Shanghai) Co., Ltd.
Masonic Cancer Center, University of Minnesota
Merck KGaA, Darmstadt, Germany
Celgene
Mirna Therapeutics, Inc.
University of Pittsburgh
Merck Sharp & Dohme LLC
Indiana University
University of Louisville
Novartis
National Cancer Institute (NCI)
Rennes University Hospital
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center